SAFINAMIDE | SAFINAMIDE | ATC N04BD03
NERVOUS SYSTEM ADJUNCTIVE TREATMENT TO LEVODOPA/CARBIDOPA IN PATIENTS WITH PARKINSON'S DISEASE MONOAMINE OXIDASE TYPE B (MAO-B) INHIBITOR BLOCKS THE CATABOLISM OF DOPAMINE 1000-FOLD SELECTIVITY OVER MAO-A | ORAL | Tmax 2.5 HOUR F 95 PERCENT VD 165 LITER PPB 88 PERCENT Cl 4.6 LITER / HOUR HT 23 HOUR SOLUBILITY SOLUBLE IN WATER BUT SHOWS LOW SOLUBILITY (<0.4 MG/ML) AT PH 6.8 AND 7.5 | MONOAMINE OXIDASE TYPE B (MAO-B) | Amine oxidase flavin-containing B UNIPROT P27338 MAOB more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |